The Pulse Today
BREAKING
Sajib Pledges Aid for 50,000 Flood-Affected People in SonargaonMP Azharul Islam Mannan Distributes Relief Funds to Needy Families in SonargaonParliament Proposes Anti-Gambling Bill with Maximum 7-Year Prison PenaltyOpenAI Unveils 'Schedule' Feature to Boost Task Management in AI ChatbotPrime Minister Tareq Rahman Arrives in Dalian, China for Economic ForumEurope Confronts Intense Heatwave; Conditions Predicted to DeteriorateGold Prices Rise Again in Bangladesh Amid Global Market IncreaseSpaceX's Nasdaq Debut Values Company at Over $2 Trillion, Surpassing AmazonStudy Reveals AI Data Centers Contribute to Local Temperature IncreasesNarayanganj BNP Youth Wing Holds Rally to Welcome New Central CommitteeGovernment Announces Plan to Construct International-Standard Sports Villages in Every DistrictKobir Urges Global Pressure on Myanmar for Safe Rohingya Return172 Individuals Detained in Large-Scale Anti-Drug Operations Across ChattogramZahir Uddin Swapon Advocates for Quality Films to Revitalize Bangladesh's CinemaKhulna BNP to Mark 48th Founding Anniversary with Extensive ProgrammePM Tarique Rahman's Commitment to Disability Rehabilitation RecognizedMilon Advocates Curriculum Reform and Quality Research to Transform Higher EducationExcelerate Energy's FSRU Restarts, Enhancing Bangladesh's Natural Gas SupplySayeed Al Noman Urges End to Old Politics Following July UprisingNationwide Preventive Oral Cholera Vaccination Campaign Launches in BangladeshRangpur Celebrates Mirza Fakhrul's Presidential Win and Ruhul Kabir Rizvi's New Party RoleExperts Urge Coordinated Reforms to Boost Private Investment in Bangladesh11-Year-Old Madrasa Student Dies in Cox’s Bazar Road AccidentUGC Announces Higher Education Academy to Enhance University Faculty TrainingYunnan Entrepreneurs Encouraged to Invest in Bangladesh's Growing Economy

India Approves First Dengue Vaccine: Takeda's Qdenga Jab Authorized

India has approved its first dengue vaccine, authorising the use of Japanese drugmaker Takeda's Qdenga jab.

By Staff Correspondent
Share
India approves first dengue vaccine | International
BSS

India has approved its first dengue vaccine, authorising the use of Japanese drugmaker Takeda's Qdenga jab, the health ministry said on Tuesday. The Central Drugs Standard Control Organisation (CDSCO) approved the vaccine for people aged four to 60 after reviewing its quality, safety, and efficacy.

Qdenga is given as two injections, three months apart, and protects against all four dengue virus serotypes. It is approved in 42 countries and has received World Health Organization (WHO) prequalification.

Takeda has a collaboration with Indian vaccine maker Biological E to expand the drug's manufacturing. The vaccine has been distributed in more than 24 million doses worldwide with no major safety concerns reported so far.

Dengue has spread rapidly due to urbanisation, climate change, and changing weather patterns. The WHO estimates nearly half the world's population is at risk, with 100 million to 400 million infections each year. Since 2021, India has reported over one million dengue cases and at least 1,500 deaths.

India is also set to get its own dengue vaccine with Panacea Biotec's candidate, DengiAll, having entered the final stage of clinical trials. Once approved, it would become one of the world's first single-dose dengue vaccines. This development is particularly significant for Bangladesh, which shares similar climatic conditions and faces a high burden of dengue cases.

Source: BSS

Topics

Comments

More in Health

See all →

Latest stories